Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Bill Haddad

1664 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General

UPDATE: Voyager Eligible For Up To $290M In Associated Milestone Payments

By Bill Haddad
October 4, 7:03 AM
Under the terms of the license option agreement, originally announced in October 2021, Voyager previously received a $30 million upfront payment and is entitled to receive a $10 million option exercise payment. Voyager

PFE

Read More
3 minute read
  • Biotech
  • General

Connect Biopharma Reports CBP-201 Achieved All Primary And Key Secondary Endpoints In Pivotal Atopic Dermatitis (AD) Trial In China

By Bill Haddad
October 4, 7:01 AM
All primary and key secondary endpoints were met and highly significant at Week 16 in 255 adult patients with moderate-to-severe AD Safety and tolerability results for CBP-201 consistent with targeting the

CNTB

Read More
2 minute read
  • General

Materion Announces $20M In Investments In Massachusetts Facility To Expand Capacity

By Bill Haddad
October 4, 6:50 AM
Materion Corporation (NYSE:MTRN), a world leader in high-performing advanced materials, announced today that it is investing more than $20 Million in its recently acquired Newton, Massachusetts facility. The investments

MTRN

Read More
2 minute read
  • M&A

Velodyne Lidar Acquires Bluecity; Terms Not Disclosed

By Bill Haddad
October 4, 6:48 AM
Velodyne Lidar, Inc. (NASDAQ:VLDR, VLDRW)) today announced the company has acquired Bluecity, a Montreal-based artificial intelligence (AI) software company whose next-generation, lidar-based solutions solve safety,

VLDR

Read More
1 minute read
  • General

IGT Resort Wallet And IGTPay Modules Are Deployed At Six Station Casinos Las Vegas Properties

By Bill Haddad
October 4, 6:47 AM
International Game Technology PLC ("IGT") (NYSE:IGT) today announced that its award-winning Resort Wallet and IGTPay cashless gaming modules of the IGT ADVANTAGE™ casino management system are deployed at

IGT

Read More
3 minute read
  • Biotech
  • General

ChromaDex Announces Findings From Study On Safety And Tolerability Of Nicotinamide Riboside In Heart Failure With Reduced Ejection Fraction

By Bill Haddad
October 4, 6:34 AM
This is the first study to investigate the safety and tolerability of NR in a randomized, placebo-controlled trial of patients with heart failure, marking a milestone for future clinical research LOS ANGELES--(BUSINESS

CDXC

Read More
1 minute read
  • General

Trane Technologies Announces Thermo Kind Has Completed Initial Testing Of Evolve Electric Trailer With Walmart, Loblaws And Martin Brower

By Bill Haddad
October 4, 6:33 AM
Thermo King®, a leader in transport temperature control solutions and a brand of Trane Technologies (NYSE:TT), has completed initial testing of its innovative evolve™ electric trailer with retailers Walmart and

TT

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

KalVista Pharmaceuticals Announces Termination Of KVD824 Phase 2 KOMPLETE Trial For Prophylactic Treatment Of Hereditary Angioedema

By Bill Haddad
October 4, 6:31 AM
  - Safety signals observed will not yield targeted product profile – - No impact on Sebetralstat expected safety profile or Phase 3 KONFIDENT trial – - Oral Factor XIIa program to become primary

KALV

Read More
1 minute read
  • General

Swvl Says Operations In 5 Of Top 10 Countries By Revenue Turned Adj. EBITDA Positive Or Breakeven In Aug.

By Bill Haddad
October 4, 6:07 AM
Swvl Holdings Corp (“Swvl” or the “Company”) (NASDAQ:SWVL), a global provider of transformative tech-enabled mass transit solutions, today announced that operations in 5 of its 10 top countries by

SWVL

Read More
1 minute read
  • News
  • Stock Split

Quanergy Announces 1-for-20 Reverse Stock Split; Will Begin Trading On Split-Adjusted Basis Oct. 7

By Bill Haddad
October 4, 6:03 AM
Quanergy Systems, Inc., (NYSE:QNGY) (“Quanergy” or the “Company”) a leading provider of LiDAR sensors and smart 3D solutions, announced today that its Board of Directors has approved a reverse

QNGY

Posts pagination

Previous 1 … 61 62 63 … 167 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service